Skip to main content
BGM logo

BGM Group Ltd. (BGM) Stock Price & Analysis

BGM Group Ltd. (BGM) — MoonshotScore 46/100 (Fair band), calculated Oct 5, 2026. Price $9.35 (+0.11%), as of the Oct 5, 2026 trading session; market cap $119M.

Educational signal · not a buy or sell recommendation · How to read this

$9.35 +$0.01 (+0.11%) Market Cap $119M

BGM Group Ltd. · BGM · NASDAQ

BGM Group Ltd. is a Chinese manufacturer and distributor of active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and organic fertilizers. The company's diverse product portfolio includes licorice extracts, oxytetracycline tablets, and sausage casings.

Price as of Oct 5, 2026

Key Statistics

46 of 100

MoonshotScore v2 · BGM Group (BGM)

Fair
Business Quality Average (45)
Financial Safety Strained (23)
Valuation Fair (68)
Growth Durability Shrinking (11)
Momentum Slipping (22)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Cheap, but a fragile balance sheet, stalling growth and average quality, and the price trend has turned against it. Business Quality: Average; Financial Safety: Strained; Valuation: Fair; Growth Durability: Shrinking; Momentum: Slipping.

  • quarterly revenue $24M (Q2 FY2026, quarter ended Mar 2026)
  • ROE -3.4% · ROA -2.7% · current ratio 3.39 · earnings yield -47.0% · free-cash-flow yield -4.0%

Holding back: balance-sheet strain, soft growth, weak price trend

Helping: an attractive price

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for BGM (30 recorded, newest six shown)
RecordedScoreBand
45Fair
45Fair
45Fair
45Fair
45Fair
46Fair

The score was 46 in the stored Oct 4, 2026 snapshot and remains 46 in the current publication computed Oct 5, 2026 (0); the largest pillar moves were Growth Durability +1 and Momentum -1; the pillar moves offset under the sector-relative weighting, so the headline score is unchanged.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · Educational signal · not a buy or sell recommendation · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$9.35
Change on the day+0.11%
52-week range$6.45 – $311.40
Market capitalisation$119M
Shares traded on the day4.5K

Price & events

Other perspectives

Council score for BGM Group (BGM): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Growth Durability Negative
Momentum Negative
Business Quality Neutral
Financial Safety Weak
Valuation Moderate

Legends Council

3 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Englander-style lens (simulated) Izzy Englander Unfavorable read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Unfavorable read

Read on: Oct 1, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Weak
Margin of Safety Fairly Valued
Profit Margin Weak
Revenue Growth Strong
Debt/Equity Strong
ROE Negative
Gross Margin Weak

Read on: Sep 11, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Sep 11, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Oct 6, 2026, except a card that shows its own read date.

Watch the BGM film — every key number, told as a short cinematic story

~2 min · open the film

1 · What is it?

What is BGM Group (BGM), and what does it report?

Short answer · as of

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. BGM Group Ltd. (BGM) is listed on NASDAQ. It employs 298 people and is led by Chen Xin. In Q2 FY2026 it reported revenue of $24M and net income of -$2M. The market values it at $119M.

2 · Latest results

What do the latest results show for BGM Group (BGM)?

Short answer · as of

The most recent reported quarter, Q2 FY2026, carried revenue of $24M.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q2 FY2026$24M-$2M-$0.01 (diluted)
Q4 FY2025$24M-$19M-$0.15 (diluted)
Q2 FY2025$14M-$861,220-$0.03 (diluted)
Q2 FY2024$13M$328,780$0.05 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for BGM Group (BGM)?

Short answer

The MoonshotScore pillars rate an attractive price as strengths. What is holding it back is balance-sheet strain, soft growth, weak price trend. Trailing ratios: ROE -3.4% · ROA -2.7% · current ratio 3.39 · earnings yield -47.0% · free-cash-flow yield -4.0%.

5 · Peer comparison

How does BGM Group compare with its peers?

Short answer

BGM Group's score ranks tied for 4th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Embecta Corp. (EMBC) Same industry, near in market value$5.88 Oct 5, 2026$349M78 5-pillar Oct 5, 2026
Edgewise Therapeutics, Inc. (EWTX) Named competitor$40.30 Oct 5, 2026$4.34B66 5-pillar Oct 5, 2026
Cardiol Therapeutics Inc. (CRDL) Same industry, near in market value$1.32 Oct 5, 2026$152M54 5-pillar Oct 5, 2026
BGM Group (BGM) — this page$9.35$119M46
Zhengye Biotechnology Holding Limited (ZYBT) Same industry, near in market value$1.24 Oct 2, 2026$58.8M46 5-pillar Oct 5, 2026
Incannex Healthcare Limited (IXHL) Same industry, near in market value$3.21 Oct 2, 2026$38.4M43 5-pillar Oct 5, 2026
Organogenesis Holdings Inc. (ORGO) Same industry, near in market value$1.31 Oct 5, 2026$169M36 5-pillar Oct 5, 2026
Organigram Global Inc. (OGI) Same industry, near in market value$0.94 Oct 5, 2026$132M35 5-pillar Oct 5, 2026
Journey Medical Corporation (DERM) Same industry, near in market value$6.69 Oct 5, 2026$184M35 5-pillar Oct 5, 2026
SIGA Technologies, Inc. (SIGA) Same industry, near in market value$3.54 Oct 5, 2026$254M35 5-pillar Oct 5, 2026
Cumberland Pharmaceuticals Inc. (CPIX) Same industry, near in market value$7.09 Oct 5, 2026$106M34 5-pillar Oct 5, 2026
SNDL Inc. (SNDL) Same industry, near in market value$1.24 Oct 2, 2026$362M34 5-pillar Oct 5, 2026
InterCure Ltd. (INCR) Same industry, near in market value$5.42 Oct 2, 2026$64.2M31 5-pillar Oct 5, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

What has been published about BGM Group (BGM)?

Read these with our analysis →

Investor Questions: BGM Stock

These answers are editorial: 1 of these 9 answers is drawn from the BGM research dossier (written May 10, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for BGM?

BGM carries the MoonshotScore stated above — the Fair band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Is BGM a good stock to buy?

Stock Expert AI does not rate BGM buy, sell or hold. BGM Group Ltd. carries a MoonshotScore, in the Fair band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the BGM stock price today?

The last price recorded on this page for BGM Group Ltd. (BGM) is $9.35, as of the Oct 5, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What are the key growth opportunities for BGM in healthcare?

BGM Group Ltd. can expand its presence in the healthcare sector by developing new pharmaceutical products, increasing its penetration of the TCM market, and forming strategic partnerships with other healthcare companies.

What are the key factors to evaluate for BGM?

BGM Group Ltd. (BGM) holds a MoonshotScore in the low range. No dividend yield reflects a focus on reinvesting earnings for growth rather than returning capital to shareholders. Not financial advice.

How frequently does BGM data refresh on this page?

BGM's price is the last quote we recorded, from the Oct 5, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven BGM's recent stock price performance?

BGM Group Ltd. (BGM) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product portfolio across pharmaceuticals and agriculture. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider BGM overvalued or undervalued right now?

BGM Group Ltd. (BGM) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of BGM?

Fractional-share availability for BGM Group Ltd. (BGM) depends on your brokerage, account and supported securities. Check the broker's current eligibility, minimums and fees before placing an order.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources — records for every figure on this page (14 figures)

The 14 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.

"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.

FMP — 8 facts from Financial Modeling Prep endpoint families

FMP facts used on this page
Fact IDFactValue as shownAs ofTierSource
px.lastLatest provided price$9.35FMPFinancial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-05T21:44:51.987Z.
px.changeChange on the day+0.11%FMPFinancial Modeling Prep (FMP) · quote
px.mcapMarket capitalisation$119MFMPFinancial Modeling Prep (FMP) · quote — Date unknown Market cap record date: 2026-10-05. FMP quote timestamp: 2026-10-05T20:00:00.000Z. Captured from FMP at 2026-10-05T21:44:51.010Z. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares.
px.change_absChange on the day, in dollars+$0.01FMPFinancial Modeling Prep (FMP) · quote
fin.q_revenueRevenue, Q2 FY2026$24MFMPFinancial Modeling Prep (FMP) · income statement (quarterly)
px.volumeShares traded on the day4.5KFMPFinancial Modeling Prep (FMP) · quote
fin.q_incomeNet income, Q2 FY2026-$2MFMPFinancial Modeling Prep (FMP) · income statement (quarterly)
fin.q_tableQuarterly income statement4 quarters through Q2 FY2026FMPFinancial Modeling Prep (FMP) · income statement (quarterly), as filed

UNRECORDED — 4 facts from stored observations whose source was not recorded

UNRECORDED facts used on this page
Fact IDFactValue as shownAs ofTierSource
fin.ratiosReturn and yield ratios (trailing twelve months)ROE -3.4% · ROA -2.7% · current ratio 3.39 · earnings yield -47.0% · free-cash-flow yield -4.0%—UNRECORDEDStored key metrics — Date unknown
px.range5252-week range$6.45 – $311.40UNRECORDEDStored company-profile observation — Captured 2026-10-04
id.employeesEmployees298UNRECORDEDStored company-profile observation — Captured 2026-10-04
id.ceoChief executiveChen XinUNRECORDEDStored company-profile observation — Captured 2026-10-04

OURS — 2 facts from Stock Expert AI's own score and rank

OURS facts used on this page
Fact IDFactValue as shownAs ofTierSource
ours.moonshotMoonshotScore v246 of 100 · Fair · pillars 45 / 23 / 68 / 11 / 22OURSStock Expert AI MoonshotScore v2 engine
ours.moonshot_changeMoonshotScore movement46 (stored snapshot Oct 4, 2026) → 46 (current publication computed Oct 5, 2026) (0)OURSStock Expert AI current score publication and immutable score snapshots
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.